Study of Oglemilast for the Prevention of Asthma.

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Exercise-Induced Asthma

Interventions

DRUG

Oglemilast

Oglemilast, 15mg once per day, oral administration

DRUG

Placebo

Dose-marched placebo, once per day, oral administration

Trial Locations (2)

Forest Investigative Site, Los Angeles

Forest Investigative Site, North Dartmouth